Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.07%
1,101.37
-0.81
-0.07%
—1,102.181,096.241,103.051,090.35——
SIXC
Communications
SIXC
Communications
SIXC
-0.47%
613.35
-2.89
-0.47%
—616.24616.24617.68609.10——
SIXE
Energy
SIXE
Energy
SIXE
+0.77%
1,198.83
+9.11
+0.77%
—1,189.721,194.741,202.791,188.58——
SIXI
Industrials
SIXI
Industrials
SIXI
+1.75%
1,755.95
+30.26
+1.75%
—1,725.691,730.021,762.991,730.02——
SIXM
Financials
SIXM
Financials
SIXM
-0.79%
638.51
-5.11
-0.79%
—643.62643.13643.17632.59——
SIXR
Staples
SIXR
Staples
SIXR
+1.65%
843.52
+13.73
+1.65%
—829.79832.32845.25832.32——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.19%
215.95
+2.55
+1.19%
—213.40213.40216.07213.40——
SIXT
Technology
SIXT
Technology
SIXT
-1.48%
3,138.91
-47.01
-1.48%
—3,185.923,160.893,178.723,102.60——
SIXU
Utilities
SIXU
Utilities
SIXU
+2.80%
934.37
+25.43
+2.80%
—908.94912.57934.91912.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.10%
1,477.43
-1.53
-0.10%
—1,478.961,478.171,482.911,466.65——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-1.05%
2,380.19
-25.17
-1.05%
—2,405.362,390.342,402.532,359.18——
PVH:NYSE
PVH Corp
$95.35
+1.97%
(+1.84) 1D
$95.35
0.00% (0.00)
After hours
Closed: Apr 23, 4:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PVH...
Open
$93.62
High
$96.32
Low
$93.62
Mkt. cap
4.37B
Avg. vol.
1.33M
Volume
0.00
Dividend
0.16%
Quarterly dividend
$0.04
Ex dividend date
Mar 4, 2026
P/E ratio
182.79
52-wk high
$100.00
52-wk low
$59.60
EPS
$0.52
Beta
1.61
Shares outstanding
45.81M
No. of employees
20K
News stories
From sources across the web
Profile
PVH Corp., formerly known as the Phillips-Van Heusen Corporation, is an American clothing company which owns brands such as Tommy Hilfiger and Calvin Klein. The company also licenses brands such as Kenneth Cole New York and Michael Kors. Wikipedia
About PVH Corp
CEOStefan Larsson
Employees20.5K
Founded1881
Headquarters-
SectorLuxury goods
Websitepvh.com
Last report
Apr 1, 2026
Fiscal Period
Q4 2026
Normalized EPS / Estimate
3.82/ (3.30 est.)USD
+15.68%beat
Revenue / Estimate
2.51B/ (2.43B est.)USD
+2.94%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
1.98B
2.17B
2.29B
2.51B
Cost of goods sold
821.90M
916.40M
1.00B
1.06B
Cost of revenue
821.90M
916.40M
1.00B
1.06B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.01B
1.08B
1.10B
1.19B
Operating expense
1.01B
1.08B
1.10B
1.19B
Total operating expenses
1.83B
2.00B
2.10B
2.25B
Operating income
150.00M
166.00M
192.30M
257.40M
Other non operating income
-
-
-
-
EBT including unusual items
-349.60M
111.20M
160.30M
229.40M
EBT excluding unusual items
143.10M
156.20M
181.80M
250.00M
Income tax expense
-304.80M
-113.00M
156.10M
387.70M
Effective tax rate
87.19%
-101.62%
97.38%
169.01%
Other operating expenses
-
-
-
-
Net income
-44.80M
224.20M
4.20M
-158.30M
Net profit margin
-2.26%
10.35%
0.18%
-6.32%
Earnings per share
2.30
2.52
2.83
3.82
Interest and investment income
5.00M
3.80M
2.70M
3.40M
Interest expense
-22.40M
-25.80M
-23.20M
-22.80M
Net interest expenses
-17.40M
-22.00M
-20.50M
-19.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
217.70M
232.40M
259.40M
309.60M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer